BACKGROUND. Patients who have insulin-dependent diabetes mellitus and nephropathy have an excess of cardiovascular disease. Familial factors may in part account for this phenomenon. METHODS. We identified 61 white patients under 65 years of age with insulin-dependent diabetes who had nephropathy, and then matched them with 61 diabetic patients without nephropathy. We determined the prevalence of cardiovascular disease in the parents of these patients with use of information obtained from death certificates or from the World Health Organization questionnaire for cardiovascular disease. RESULTS. The rates of ascertainment of information were 96 percent (n = 117) for the parents of diabetic patients with nephropathy and 95 percent (n = 116) for the parents of patients without nephropathy. Cardiovascular disease was more often a direct cause of death among the parents of diabetic patients with nephropathy (40 percent vs. 22 percent, P less than 0.03), and the combined morbidity and mortality from cardiovascular disease in this group was greater than that in the parents of diabetic patients without nephropathy (31 percent vs. 14 percent, P less than 0.01). The age-adjusted and sex-adjusted relative risk of cardiovascular disease in this group of parents was 2.9 (95 percent confidence interval, 1.5 to 5.5; P less than 0.001). Moreover, a paternal history of cardiovascular disease was associated with a significantly increased risk of nephropathy in the diabetic patient after the analysis was adjusted for age, sex, and duration of diabetes (odds ratio, 3.2; 95 percent confidence interval, 1.3 to 7.9; P less than 0.01). Among the diabetic patients with nephropathy, those who had had a cardiovascular event were much more likely to have a family history of cardiovascular disease (odds ratio, 6.2; 95 percent confidence interval, 2.0 to 19.0; P less than 0.005) than those who had not had such an event. CONCLUSIONS. Among patients with insulin-dependent diabetes, a parental history of cardiovascular disease is significantly associated with the development of nephropathy and, among those with nephropathy, increases the likelihood of cardiovascular disease.
Source Information
Unit for Metabolic Medicine, United Medical School, Guy's Hospital, London, United Kingdom.
This article has been cited by other articles:
Tregouet, D.-A., Groop, P.-H., McGinn, S., Forsblom, C., Hadjadj, S., Marre, M., Parving, H.-H., Tarnow, L., Telgmann, R., Godefroy, T., Nicaud, V., Rousseau, R., Parkkonen, M., Hoverfalt, A., Gut, I., Heath, S., Matsuda, F., Cox, R., Kazeem, G., Farrall, M., Gauguier, D., Brand-Herrmann, S.-M., Cambien, F., Lathrop, M., Vionnet, N., for the EURAGEDIC Consortium,
(2008). G/T Substitution in Intron 1 of the UNC13B Gene Is Associated With Increased Risk of Nephropathy in Patients With Type 1 Diabetes. Diabetes
57: 2843-2850
[Abstract][Full Text]
Thorn, L. M., Forsblom, C., Fagerudd, J., Pettersson-Fernholm, K., Kilpikari, R., Groop, P.-H., on behalf of the FinnDiane Study Group,
(2007). Clustering of Risk Factors in Parents of Patients With Type 1 Diabetes and Nephropathy. Diabetes Care
30: 1162-1167
[Abstract][Full Text]
Orchard, T. J., Costacou, T., Kretowski, A., Nesto, R. W.
(2006). Type 1 diabetes and coronary artery disease.. Diabetes Care
29: 2528-2538
[Full Text]
Vionnet, N., Tregouet, D., Kazeem, G., Gut, I., Groop, P.-H., Tarnow, L., Parving, H.-H., Hadjadj, S., Forsblom, C., Farrall, M., Gauguier, D., Cox, R., Matsuda, F., Heath, S., Thevard, A., Rousseau, R., Cambien, F., Marre, M., Lathrop, M.
(2006). Analysis of 14 Candidate Genes for Diabetic Nephropathy on Chromosome 3q in European Populations: Strongest Evidence for Association With a Variant in the Promoter Region of the Adiponectin Gene. Diabetes
55: 3166-3174
[Abstract][Full Text]
Caramori, M. L., Fioretto, P., Mauer, M.
(2006). Enhancing the Predictive Value of Urinary Albumin for Diabetic Nephropathy. J. Am. Soc. Nephrol.
17: 339-352
[Abstract][Full Text]
Strojek, K., Nicod, J., Ferrari, P., Grzeszczak, W., Gorska, J., Dick, B., Frey, F., Ritz, E.
(2005). Salt-sensitive blood pressure--an intermediate phenotype predisposing to diabetic nephropathy?. Nephrol Dial Transplant
20: 2113-2119
[Abstract][Full Text]
CY, H., CE, M., J, D., AS, G., C, I., E, T., HC, C., M, L., S, R., ER, R., B, T., G, L., N, P., KL, G., Y, W., DA, K., B, J., D, H., P, B., V, P., N, R., C, F., I, R., M, C., M, R., E, d. H., H, B., SJ, B., M, Z., E, R., P, M., MA, S., J, M., H, K., S, S., CR, B., P, N., HP, H., BA, Y., J, Z., FJ, v. d. W.
(2005). Which Comes First--Renal Dysfunction or High Blood Pressure?: Elevated Blood Pressure and Risk of End-Stage Renal Disease in Subjects without Baseline Kidney Disease. Arch Intern Med 165: 923-928, 2005. J. Am. Soc. Nephrol.
16: 2817-2820
[Full Text]
Janssen, B., Hohenadel, D., Brinkkoetter, P., Peters, V., Rind, N., Fischer, C., Rychlik, I., Cerna, M., Romzova, M., de Heer, E., Baelde, H., Bakker, S. J.L., Zirie, M., Rondeau, E., Mathieson, P., Saleem, M. A., Meyer, J., Koppel, H., Sauerhoefer, S., Bartram, C. R., Nawroth, P., Hammes, H.-P., Yard, B. A., Zschocke, J., van der Woude, F. J.
(2005). Carnosine as a Protective Factor in Diabetic Nephropathy: Association With a Leucine Repeat of the Carnosinase Gene CNDP1. Diabetes
54: 2320-2327
[Abstract][Full Text]
Hadjadj, S., Pean, F., Gallois, Y., Passa, P., Aubert, R., Weekers, L., Rigalleau, V., Bauduceau, B., Bekherraz, A., Roussel, R., Dussol, B., Rodier, M., Marechaud, R., Lefebvre, P. J., Marre, M., for the Genesis France-Belgium Study,
(2004). Different Patterns of Insulin Resistance in Relatives of Type 1 Diabetic Patients With Retinopathy or Nephropathy: The Genesis France-Belgium Study. Diabetes Care
27: 2661-2668
[Abstract][Full Text]
Sultan, A., Piot, C., Mariano-Goulart, D., Rasamisoa, M., Renard, E., Avignon, A.
(2004). Risk Factors for Silent Myocardial Ischemia in High-Risk Type 1 Diabetic Patients. Diabetes Care
27: 1745-1747
[Full Text]
Hansen, T. K., Tarnow, L., Thiel, S., Steffensen, R., Stehouwer, C. D., Schalkwijk, C. G., Parving, H.-H., Flyvbjerg, A.
(2004). Association Between Mannose-Binding Lectin and Vascular Complications in Type 1 Diabetes. Diabetes
53: 1570-1576
[Abstract][Full Text]
Huang, W., Gallois, Y., Bouby, N., Bruneval, P., Heudes, D., Belair, M.-F., Krege, J. H., Meneton, P., Marre, M., Smithies, O., Alhenc-Gelas, F.
(2001). Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc. Natl. Acad. Sci. USA
10.1073/pnas.231476798v1
[Abstract][Full Text]
Tarnow, L., Grarup, N., Hansen, T., Parving, H.-H., Pedersen, O.
(2001). Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients. Nephrol Dial Transplant
16: 1653-1656
[Abstract][Full Text]
Poirier, O., Nicaud, V., Vionnet, N., Raoux, S., Tarnow, L., Vlassara, H., Parving, H.-H., Cambien, F.
(2001). Polymorphism Screening of Four Genes Encoding Advanced Glycation End-Product Putative Receptors: Association Study With Nephropathy in Type 1 Diabetic Patients. Diabetes
50: 1214-1218
[Abstract][Full Text]
HADJADJ, S., BELLOUM, R., BOUHANICK, B., GALLOIS, Y., GUILLOTEAU, G., CHATELLIER, G., ALHENC-GELAS, F., MARRE, M.
(2001). Prognostic Value of Angiotensin-I Converting Enzyme I/D Polymorphism for Nephropathy in Type 1 Diabetes Mellitus: A Prospective Study. J. Am. Soc. Nephrol.
12: 541-549
[Abstract][Full Text]
Hadjadj, S., Gallois, Y., Simard, G., Bouhanick, B., Passa, P., Grimaldi, A., Drouin, P., Tichet, J., Marre, M.
(2000). Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein {varepsilon}, lipoprotein lipase and cholesteryl ester transfer protein. Nephrol Dial Transplant
15: 1971-1976
[Abstract][Full Text]
van Ittersum, F. J., de Man, A. M. E., Thijssen, S., de Knijff, P., Slagboom, E., Smulders, Y., Tarnow, L., Donker, A. J. M., Bilo, H. J. G., Stehouwer, C. D. A.
(2000). Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transplant
15: 1000-1007
[Abstract][Full Text]
Akasaka, T., Yoshida, K., Kawamoto, T., Kaji, S., Ueda, Y., Yamamuro, A., Takagi, T., Hozumi, T.
(2000). Relation of Phasic Coronary Flow Velocity Characteristics With TIMI Perfusion Grade and Myocardial Recovery After Primary Percutaneous Transluminal Coronary Angioplasty and Rescue Stenting. Circulation
101: 2361-2367
[Abstract][Full Text]
Tarnow, L., Stehouwer, C. D. A., Emeis, J. J., Poirier, O., Cambien, F., Hansen, B. V., Parving, H.-H.
(2000). Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy. Nephrol Dial Transplant
15: 625-630
[Abstract][Full Text]
Manske, C. L., Wilson, R. F., Wang, Y., Thomas, W.
(1992). Prevalence of, and Risk Factors for, Angiographically Determined Coronary Artery Disease in Type I-Diabetic Patients With Nephropathy. Arch Intern Med
152: 2450-2455
[Abstract]
Huang, W., Gallois, Y., Bouby, N., Bruneval, P., Heudes, D., Belair, M.-F., Krege, J. H., Meneton, P., Marre, M., Smithies, O., Alhenc-Gelas, F.
(2001). Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc. Natl. Acad. Sci. USA
98: 13330-13334
[Abstract][Full Text]
Previous
